(R)-(+)-DBD-PRO-COCI - Names and Identifiers
Name | (S)-(-)-4-(N,N-Dimethylaminosulfonyl)-7-(2-Chloroformylpyrrolidin-1-Yl)Benzofurazan
|
Synonyms | (S)-(-)-Dbd-Pro-Cocl (R)-(+)-DBD-PRO-COCI (S)-(-)-Dbd-Pro-Coci N-(7-(DIMETHYLSULFAMOYL)-4-BENZOFURAZANYL)-L-PROLYL CHLORIDE N-(7-(Dimethylsulfamoyl)-4-Benzofurazanyl)-L-Prolyl Chloride (S)-(-)-4-(N,N-Dimethylaminosulfonyl)-7-(2-Chloroformylpyrrolidin-1-Yl)Benzofurazan (S)-(-)-4-(N,N-DIMETHYLAMINOSULFONYL)-7-(2-CHLOROFORMYLPYRROLIDIN-1-YL)BENZOFURAZAN (S)-(-)-DBD-PROCZ, (S)-(-)-1-[7-(N,N-DIMETHYLSULFAMOYL)-4-BENZOFURAZANYL]-2-PYRROLIDINECARB (S)-(-)-DBD-ProCZ, (S)-(-)-1-[7-(N,N-Dimethylsulfamoyl)-4-benzofurazanyl]-2-pyrrolidinecarb (S)-(-)-4-(N,N-Dimethylaminosulfonyl)-7-(2-Chloroformylpyrrolidin-1-Yl)-2,1,3-Benzoxadiazole (S)-(-)-4-(N,N-Dimethylaminosulfonyl)-7-(2-chloroformylpyrrolidin-1-yl)benzofurazan(S)-(-)-4-(N,N-Dimethylaminosulfonyl)-7-(2-chloroformylpyrrolidin-1-yl)-2,1,3-benzoxadiazole (S)-(-)-DBD-ProCZ, (S)-(-)-1-[7-(N,N-Dimethylsulfamoyl)-4-benzofurazanyl]-2-pyrrolidinecarbonyl chloride, (S)-(-)-4-(2-Chloroformyl-pyrrolidino)-7-(N,N-dimethylsulfamoyl)benzofurazan (S)-(-)-DBD-ProCZ, (S)-(-)-1-[7-(N,N-Dimethylsulfamoyl)-4-benzofurazanyl]-2-pyrrolidinecarbonyl chloride, (S)-(-)-4-(2-Chloroformyl-pyrrolidino)-7-(N,N-dimethylsulfamoyl)benzofurazan
|
CAS | 150993-63-8
|
InChI | InChI=1/C13H15ClN4O4S/c1-17(2)23(20,21)10-6-5-8(11-12(10)16-22-15-11)18-7-3-4-9(18)13(14)19/h5-6,9H,3-4,7H2,1-2H3/t9-/m0/s1 |
(R)-(+)-DBD-PRO-COCI - Physico-chemical Properties
Molecular Formula | C13H15ClN4O4S
|
Molar Mass | 358.8 |
Appearance | powder to crystal |
Color | Light yellow to Yellow to Orange |
Storage Condition | Refrigerator |
Refractive Index | 1.623 |
MDL | MFCD00191380 |
Physical and Chemical Properties | Storage Conditions: recigerator WGK Germany:3 |
(R)-(+)-DBD-PRO-COCI - Risk and Safety
Hazard Symbols | Xi - Irritant
|
Risk Codes | 36/37/38 - Irritating to eyes, respiratory system and skin.
|
Safety Description | S26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
S36 - Wear suitable protective clothing.
|
WGK Germany | 3 |
FLUKA BRAND F CODES | 10-21 |
(R)-(+)-DBD-PRO-COCI - Introduction
(S)-(-)-4-(N,N-Dimethylaminosulfonyl)-7-(N) Benzofurazan ((S)DMPSA-CP) is an organic compound, its chemical structure contains sulfonyl and amino groups.
The compound has the following properties:
1. Appearance: a solid powder substance.
2. Properties:(S)-(-)-DMPSA-CP is a kind of chiral compounds, which has the optical properties, the polarization direction is negative rotation.
3. Solubility: Soluble in most organic solvents, such as alcohols, esters, ethers, etc.
The main uses of the
(S)DMPSA-CP are as follows:
1. Additives: can be used as photocatalyst additives, used to improve the activity and stability of photocatalyst.
2. Reagents: in organic synthesis, can be used as Chiral reagents for Chiral separation or Chiral synthesis.
Regarding the preparation method of (S)DMPSA-CP, the specific synthesis method may need to refer to relevant research literature or patent documents. In general, the synthesis method includes a multi-step reaction, it is necessary to carry out a sulfonylation reaction, a substitution reaction, or the like.
For the safety information DMPSA-CP by (S), you need to pay attention to the following:
1. Toxicity: Due to the lack of specific toxicity data, it is recommended to pay attention to personal protection during operation, storage and handling, and avoid inhalation, intake or skin contact.
2. Ignition point: no specific data are provided, avoid contact with open flame or high temperature.
3. Storage: Store in a cool, dry place, away from flammable materials, acid and alkali.
In view of (S)DMPSA-CP is a special compound, it is recommended to follow the relevant safety procedures in the experimental operation, understand the properties and safety information of the compound in detail before handling, and conduct appropriate safety assessments. At the same time, it is also recommended to obtain relevant safety data and technical guidance during operation.
Last Update:2024-04-09 19:05:46